CVE-2023-40153

Cross-site Scripting in DEXMA DEXGate

CVSS 5.4 MEDIUMEPSS 0.3%CWE-79

Vexday Risk Score

13Low

SSVC decision (CISA)

Track

No exploitation signal → monitor

CVSS 5.4EPSS 0.3%KEV nãoPoC —Nuclei —Metasploit —Patch —

Lifecycle

19 Oct 2023Published on NVD

Recommendation: Monitor — no exploitation signal at the moment.

The affected product is vulnerable to a cross-site scripting vulnerability, which could allow an attacker to access the web application to introduce arbitrary Java Script by injecting an XSS payload into the 'hostname' parameter of the vulnerable software.

CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:L/I:L/A:N

Affected products

DEXMA · DexGate

Want to know if your infrastructure is exposed to this?

Talk to TrueHacking →

References

https://www.cisa.gov/news-events/ics-advisories/icsa-23-271-02